Expanded phase I/II study of PTK787/ZK 222584 (PTK/ZK), a novel, oral angiogenesis inhibitor, in combination with FOLFOX-4 as first-line treatment for patients with metastatic colorectal cancer

Authors :: W. P. Steward
A. Thomas
B. Morgan
B. Wiedenmann
C. Bartel
U. Vanhoefer
T. Trarbach
U. Junker
D. Laurent
D. Lebwohl
Source :: Journal of Clinical Oncology. 22:3556-3556
Publication Year :: 2004
Publisher :: American Society of Clinical Oncology (ASCO), 2004.

Tools